Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
T98G |
Human brain glioblastoma cell line | ATCC CRL-1690 | Human | brain | cell line | adherent | plasmid | RNA-Interference | Metafectene PRO | publication | A. G. Mitrakas et al., Cancer Biol. Med., 2018, 15(3): 260-276, doi: 10.20892/j.issn.2095-3941.2017.0173 | Link | |
T98G |
Human brain glioblastoma cell line | ATCC CRL-1690 | Human | brain | cell line | adherent | plasmid | Metafectene PRO | application note | ![]() |
|||
T98G |
Human brain glioblastoma cell line | ATCC CRL-1690 | Human | brain | cell line | adherent | plasmid | Metafectene | publication | Z. Ping et al., Cell Cycle, 2012, 11: 10, 1999-2005, doi.org/10.4161/cc.20402 | Link | ||
T98G |
Human brain glioblastoma cell line | ATCC CRL-1690 | Human | brain | cell line | adherent | plasmid | RNA-Interference | Metafectene PRO | publication | G. D. Maurer et al., Neuro Oncology, Dec 2009; 11: 747 - 756 | Link | |
T97 |
Human uveal melanoma cell line | Human | skin | cell line | adherent | plasmid | K2 Transfection System | publication | M. Benhassine et al., Int. J. Mol. Sci., 2018, 19: 3272, doi:10.3390/ijms19103272 | Link | |||
T143 |
Human uveal melanoma cell line | Human | skin | cell line | adherent | plasmid | K2 Transfection System | publication | M. Benhassine et al., Int. J. Mol. Sci., 2018, 19: 3272, doi:10.3390/ijms19103272 | Link | |||
T142 |
Human uveal melanoma cell line | Human | skin | cell line | adherent | plasmid | K2 Transfection System | publication | M. Benhassine et al., Int. J. Mol. Sci., 2018, 19: 3272, doi:10.3390/ijms19103272 | Link | |||
T108 |
Human uveal melanoma cell line | Human | skin | cell line | adherent | plasmid | K2 Transfection System | publication | M. Benhassine et al., Int. J. Mol. Sci., 2018, 19: 3272, doi:10.3390/ijms19103272 | Link | |||
T-REx-293 |
Human embryonic kidney cell line, stably expressing tetracycline repressor (derivat of HEK293) | Human | urinary system | cell line | adherent | plasmid | Metafectene | publication | N. Keinan et al., Mol. Cell. Biol., Dec 2010; 30: 5698 - 5709 | Link | |||
T-REx-293 |
Human embryonic kidney cell line, stably expressing tetracycline repressor (derivat of HEK293) | Human | urinary system | cell line | adherent | plasmid | stable transfection | Metafectene | publication | S.-B. M. Varda et al., 2012, WO 2007/043049 | Link | ||
T-REx-293 |
Human embryonic kidney cell line, stably expressing tetracycline repressor (derivat of HEK293) | Human | urinary system | cell line | adherent | plasmid | RNA-Interference | Metafectene | publication | S. Abu-Hamad et al., J. Biol. Chem., May 2008; 283: 13482 - 13490 | Link | ||
T-REx-293 |
Human embryonic kidney cell line, stably expressing tetracycline repressor (derivat of HEK293) | Human | urinary system | cell line | adherent | plasmid | Metafectene | publication | S.-B. Varda et al., 2012, EP 2 371 846 | Link | |||
T-REx-293 |
Human embryonic kidney cell line, stably expressing tetracycline repressor (derivat of HEK293) | Human | urinary system | cell line | adherent | plasmid | Metafectene | publication | V. Shoshan-Barmatz et al., 2014, US 8,648,045 (Patent) | Link | |||
T-REx-293 |
Human embryonic kidney cell line, stably expressing tetracycline repressor (derivat of HEK293) | Human | urinary system | cell line | adherent | plasmid | Metafectene | publication | N. Arbel et al., J. Biol. Chem., Feb 2010; 285: 6053 - 6062 | Link | |||
T-47D |
Human breast cancer cel line | ATCC HTB-133 | Human | breast | cell line | adherent | plasmid | K2 Transfection System | publication | B. Ljepoja et al.,The Breast, 2019, 43: 31-38, doi.org/10.1016/j.breast.2018.10.007 | Link | ||
SYF |
Mouse embryonic fibroblast cell line, immortalized with SV40 large T antigen | ATCC CRL-2459 | Mouse | unknown | cell line | adherent | plasmid | Metafectene | publication | C. Neumann-Giesen et al., J. Cell Sci., Feb 2007; 120: 395 - 406 | Link | ||
SW982 |
Human synovial sarcoma cell line | ATCC HTB-93 | Human | other | cell line | adherent | plasmid | Metafectene PRO | application note | ![]() |
|||
SW620 |
Human colon adenocarcinoma cell line | ATCC CCL-227 | Human | digestive organs | cell line | adherent | plasmid | RNA-Interference | Metafectene | publication | C. A. Duckworth et al., Oncotarget, 2015, 6(27): 23671-23687 | Link | |
SW620 |
Human colon adenocarcinoma cell line | ATCC CCL-227 | Human | digestive organs | cell line | adherent | plasmid | Metafectene | publication | J. Pahle et al., BMC Cancer, 2017, 17:129, DOI 10.1186/s12885-017-3123-x | Link | ||
SW480 |
Human colon adenocarcinoma cell line | ATCC CCL-228 | Human | digestive organs | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | A. Pichorner, Dissertation, 2012 , Charité – Universitätsmedizin Berlin | Link | |
SW480 |
Human colon adenocarcinoma cell line | ATCC CCL-228 | Human | digestive organs | cell line | adherent | plasmid | Metafectene | publication | M. P.V. Shekhar et al., Mol. Cancer Res., Oct 2006; 4: 729 - 745 | Link | ||
SW480 |
Human colon adenocarcinoma cell line | ATCC CCL-228 | Human | digestive organs | cell line | adherent | plasmid | K2 Transfection System | publication | Y. Kuslansky et al., Journal of General Virology, 2016, 97: 3313-3330, DOI 10.1099/jgv.0.000624 | Link | ||
SW480 |
Human colon adenocarcinoma cell line | ATCC CCL-228 | Human | digestive organs | cell line | adherent | plasmid | Metafectene | publication | D. Kobelt, Dissertation, 2012, Humboldt-Universität zu Berlin | Link | ||
SW480 |
Human colon adenocarcinoma cell line | ATCC CCL-228 | Human | digestive organs | cell line | adherent | plasmid | Metafectene | application note | ![]() |
|||
SW480 |
Human colon adenocarcinoma cell line | ATCC CCL-228 | Human | digestive organs | cell line | adherent | plasmid | RNA-Interference | Metafectene | publication | M. P.V. Shekhar et al., Cancer Res., Mar 2008; 68: 1741 - 1750 | Link |